All In MedTech

Company

Neurologica

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $12.0M raised of $12.0M sought, first sale Dec 29, 2011, 3 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Dec 29, 2011Equity$12.0M$12.0M3Rule 506Form D ↗Jan 10, 2012

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
NEUROLOGICA CORP
Headquarters
Danvers, Massachusetts
Incorporated
Massachusetts over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    6 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Neurologica.

    Latest FDA decisions

    The 8 newest of 13 since 2015.

    Search the Clearance Tracker

    12 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    No device trials list this company as lead sponsor.

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 241000
    Feb 240000
    Mar 247000
    Apr 241000
    May 243000
    Jun 240000
    Jul 241000
    Aug 241000
    Sep 243000
    Oct 241000
    Nov 241000
    Dec 242000
    Jan 252000
    Feb 253000
    Mar 254000
    Apr 252000
    May 250000
    Jun 253000
    Jul 254000
    Aug 251000
    Sep 251000
    Oct 250000
    Nov 252000
    Dec 256000
    Jan 264000
    Feb 266000
    Mar 260000
    Apr 260000
    May 260000
    Jun 260000
    Jul 260000
    Aug 260000
    Sep 260000
    Oct 260000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    4 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    12 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.